Research
Search
Close
HE Qi
- Graduate Supervisor, Associate Chief Physician
- Department: Hematology
- Research Area: Internal Medicine (Hematology)
- Research Interests: Pathogenesis of myelodysplastic syndromes
- Contact: qi_he2000@aliyun.com
- Visiting scholar at Cincinnati Children's Hospital Medical Center, USA, 2018
- PhD from Shanghai Jiao Tong University School of Medicine, 2016
- Physician, Department of Hematology, Shanghai Sixth People's Hospital, 2004
- MD from Xinxiang Medical College, 2001
- Associate Chief Physician, Department of Hematology, Shanghai Sixth People's Hospital
- Qi H, Xiao L, Lingyun W, Ying T, Yi-Zhi L, Shao-Xu Y, Quan P. Expression of type 1 insulin-like growth factor receptor in marrow nucleated cells in malignant hematological disorders: correlation with apoptosis. Ann Hematol. 2006 Feb;85(2):95-101. Epub 2005 Nov 23.
- He Q, Li X, Zhang Z, Zhang Q, Xu F, Yang L, Tao Y, Liu Y. Overexpression of IGF-IR in malignant clonal cells in bone marrow of myelodysplastic syndromes. Cancer Invest. 2010 Dec;28(10):983-8. Epub 2010 Jun 22.
- Qi H, Qingxia Z, Xiao L, Lingyun W, Feng X, Zheng Z, Chunkang C. Recurrent Abnormal Clones in Myelodysplastic Syndrome Marrow Originate from Cells at a Pluripotent Stem Level and Maintain Their Early Differentiation Potency. Cancer Invest. 2015;33(8):369-77. Epub 2015 Jul 2.
- He Q, Chang CK, Xu F, Zhang QX, Shi WH, Li X. Purification of Bone Marrow Clonal Cells from Patients with Myelodysplastic Syndrome via IGF-IR. PLoS One. 2015 Oct 15;10(10):e0140372. doi: 10.1371/journal.pone.0140372. eCollection 2015.
- Feng Xu, Qi He, Xiao Li, Chun-Kang Chang, Ling-Yun Wu, Zheng Zhang, Li Liu, Wen-Hui Shi, Yang Zhu, You-Shan Zhao, Shu-Cheng Gu, Cheng-Ming Fei, Juan Guo, Dong Wu, Liyu Zhou. Rigosertib as a selective anti-tumor agent can ameliorate multiple dysregulated signaling transduction pathways in high-grade myelodysplastic syndrome. Sci Rep. 2014; 4: 7310. Published online 2014 Dec 4. doi: 10.1038/srep07310.
- Zheng Zhang, Qi He, Ying Tao, Juan Guo, Feng Xu, Ling-Yun Wu, You-Shan Zhao, Dong Wu, Li-Yu Zhou, Ji-Ying Su,Lu-Xi Song, Chao Xiao, Xiao Li, Chun-Kang Chang. Decitabine treatment sensitizes tumor cells to T-cell-mediated cytotoxicity in patients with myelodysplastic syndromes.Am J Transl Res. 2017; 9(2): 454–465.
- He Q, Zheng Q, Xu F, Shi W, Guo J, Zhang Z, Zhao S, Li X, Chang C. IGF_x005f IR promotes clonal cell proliferation in myelodysplastic syndromes via inhibition of the MAPK pathway. Oncol Rep. 2020 Sep;44(3):1094-1104.
